APOE and Alzheimer disease: The world APOE4 frequency varies 9–23% (i.e., Asian 9%, Hispanic 12%, white 14%, African descent 19%, other/mixed race 23%) and dramatically increases in AD patients (Hispanic 24%, Asian 28%, African descent 35%, white 38%, other/mixed race 45%) [21].